ICP-033

N/A

Report date: 2025/06/11 16:39:40

NME

Base Information

Drug NameICP-033

Drug Alias NameICP-033

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDiscoidin domain receptor 1 antagonistsDiscoidin domain-containing receptor 2 inhibitorsVascular endothelial growth factor receptor 2 inhibitors +[6]

TargetsDiscoidin domain receptor 1Discoidin domain-containing receptor 2Vascular endothelial growth factor receptor 2 +[6]

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesBeijing Innocare Pharma Tech Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Innocare Pharma Tech Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A